IgA-producing lymphoplasmacytic lymphoma carrying the chromosomal abnormality t(8;14)
Yuta Gotoh, 1) Yumi Aoyama, 1) Hiroko Tsunemine, 1) Yuka Idei, 2) Ayano Mori, 3) Taiichi Kodaka, 1) Sachiko Iba, 4) Akihiro Tomita, 4) Tomoo Itoh, 5) Takayuki Takahashi 1) IgA-producing lymphoplasmacytic lymphoma (LPL) is rare and IgH/c-myc translocation is rare in LPL. This is the first report of a case of IgA-producing LPL carrying t (8;14) . An 86-year-old woman presented inguinal and intra-abdominal lymph node swelling, and lytic bone lesions in the lumbar vertebrae. A diagnosis of IgA-producing LPL was immunohistochemically made by inguinal lymph node biopsy. The serum IgA level was 1,180 mg/dL, which was revealed to be composed of IgA-λ monoclonal protein. Bone marrow chromosomal analysis demonstrated a complex abnormal karyotype, including t(8;14)(q24;q32), which was confirmed by FISH analysis. Abnormal lymphocytes positive for CD19, CD20, cyIgA, and cyλ were detected on flow cytometry analysis of marrow cells. Best supportive care was selected because of dementia and refractory urinary tract infection. Circulating lymphoplasmacytic cells with the same phenotype and karyotype were observed, and increased in number. The aggressive clinical course, including lytic bone lesions, may have been due to IgH/c-myc translocation or the nature of IgA-producing LPL.
Keywords: lymphoplasmacytic lymphoma, IgA, t(8;14)(q24;q32), non-IgM paraprotein, MyD88 L265P superficial lymph node swelling nor hepatosplenomegaly was noted. Cognitive dysfunction, such as recent memory disturbance and disorientation, was confirmed. Laboratory examination revealed a white blood cell (WBC) count of 4.2×10 9 /L with 0.4% abnormal lymphocytes, a hemoglobin concentration of 10.6 g/dL, and a platelet count of 245×10 9 /L. Serum concentrations of IgA, C-reactive protein (CRP), and soluble interleukin-2 receptor (sIL-2R) increased to 1,180 mg/dL (normally 110 to 410 mg/dL), 1.0 mg/dL (normally below 0.3 mg/dL), and 839 U/mL (normally 145 to 519 U/mL), respectively. Serum electrophoresis demonstrated an M peak, which was revealed to be IgA-λ by immunofixation. The serum concentration of lactate dehydrogenase (LDH) was 192 IU/dL (normally 120 to 230 IU/dL); however, the LDH concentration exceeded 700 IU/mL in December 2016 when circulating LPL cells increased in number. Many WBC and bacteria were noted in the urinary sediment, and multidrugresistant Citrobacter freundii was detected at more than 10 9 / mL in urine bacterial culture.
On abdominal CT at the previous hospital, para-aortic lymph node swelling, L4 vertebral body destruction, tumoral invasion around L4 and L5 vertebral bodies, and right inguinal lymph node swelling were observed ( Figure 1 ). Histopathological examination of a biopsied inguinal lymph node revealed a mosaic pattern with medium-sized lymphocytes and plasma cells or lymphocytes exhibiting differentiation toward plasma cells ( Figure 2 ). On immunohistochemical examination, these abnormal lymphocytes were positive for CD20 (weakly), IgA, and λ-light chain ( Figure 3A , C, D, respectively), but negative for CD138 ( Figure 3B ) and CD56 (data not shown). A diagnosis of IgA-producing LPL was made. However, c-myc staining, which was performed at A mosaic pattern with medium-sized mature lymphocytes (the left half of the field), which were smaller than vascular endothelial cells (arrows), and plasma cells or lymphocytes, which exhibited plasmacytic differentiation (the right half of the field), were observed (H-E staining, ×200). Best supportive care and no chemotherapy were selected because of dementia and persistent refractory urinary tract infection, and irradiation of L4/L5 was performed to relieve the severe low back pain. Two months after admission (December 2016), lymphoplasmacytic cells were observed in the peripheral blood and gradually increased in number to approximately 15% of the WBC. On chromosomal analysis of peripheral blood at this time, the same abnormal karyotype was noted in 10 of the 20 cells analyzed ( Figure 5 ). No other abnormal karyotype was found in 2 chromosomal analyses (October 2016: bone marrow; December 2016: peripheral blood). The t(8;14) FISH analyses of the peripheral blood were performed twice in December 2016, revealing IgH/c-myc fusion signals in 8.0 and 24.0% of the circulating mononuclear cells, respectively ( Figure 6 ). FCM analysis of the peripheral blood demonstrated abnormal lymphocytes with the same phenotype as previously described in the bone marrow analysis, comprising 22.5% of the WBC; 
DISCUSSION
The clinical features of the present patient were slightly aggressive, exhibiting destructive bone lesions, possibly due to the presence of t(8;14)(q24;q32) or the nature of IgAproducing LPL, compared with those in cases of conventional IgM-producing LPL. Therefore, we performed immunostaining for c-myc using the biopsied lymph node, which was negative, suggesting a different role for c-myc in lymphoma growth in the present patient because this oncogene potently promotes neoplastic growth in Burkitt lymphoma 5 or double-hit/double expressor diffuse large B-cell type malignant lymphoma (DLBCL). 9, 10 In DLBCL, c-myc immunostaining becomes positive when c-myc is solely rearranged and involved in tumorigenesis, but it becomes negative when the c-myc rearrangement is secondary to clonal evolution of pre-existing chromosomal abnormalities. 11 In this situation, the t(8;14)(q24;q32) observed in the present patient may have been an additional chromosomal abnormality. However, independent of t(8;14), non-IgM-producing LPL, especially the IgA-producing type, exhibits more aggressive clinical features, including extramedullary lesions or organ 
Fusion signal
Fusion signal involvement, than IgM-producing LPL. 4 In addition, as recurrent chromosomal abnormalities involved in LPL tumorigenesis, del6q, t(9;14)(p13:q32), trisomy 4, trisomy 12, and +18q22.1 have been reported. 12 However, none of these were observed in the abnormal karyotype in the present patient. Therefore, the genetic background in this case may be highly unique among LPL.
Due to the lytic bone lesions in the present patient, IgAtype multiple myeloma was considered. However, myeloma was able to be ruled out by the following findings: First, the surface antigen expression of the biopsied lymph node cells was typical of LPL in terms of CD19 + , CD20 + , CD38 + , sm/ cyIgA-λ + , and CD138 -1,2 ; second, the abnormal cells in the bone marrow were morphologically lymphoplasmacytic cells composed of 2.3% nucleated cells (Figure 4 ) and the percentage of cells with typically plasmacytic morphology was 1.4%; third, the lymph node was histologically consistent with LPL (Figures 2, 3) , and t (11;14) , which is observed in a subset of multiple myeloma cases with lymphoplasmacytic morphology, 13, 14 was absent on chromosomal analysis; and fourth, the number of enlarged lymph nodes observed in the present patient is atypical for multiple myeloma.
In the present patient, MyD88 L265P mutation was not observed. Regarding this result, the incidence of this mutation in non-IgM-producing LPL has been reported to be as low as 43%. 15 Although the reason for this low incidence is unclear, the genetic background of the development of non-IgM-producing LPL may be different from that of conventional IgM-producing LPL, as in IgM-producing LPL associated with cold hemagglutinemia in which MyD88 L265P mutation is absent. 16 Furthermore, isotype switching from IgM to IgG or IgA during the course of IgM-producing LPL/Waldenström's macroglobulinemia is only rarely observed. 17 In this context, the genetic mechanism of the development of non-IgM-producing LPL may be different from that of IgM-producing LPL.
In conclusion, we report the first case of IgA-producing LPL carrying t(8;14)(q24;q32) in which MyD88 L265P mutation was negative and c-myc expression was limited. Further chromosomal and molecular investigations are required to elucidate the molecular mechanism underlying the development of LPL, including its subtypes.
